[1]
P. Marchiori Cacilhas, Y. Silva Guimarães, P. Moura Barrios, and P. Emmanuel Rubini Liedke, “Future directions on Antibody-Drug Conjugates in HER-2 negative Breast Cancer: a Comprehensive Review of New Agents”, ijmsci, vol. 11, no. 03, pp. 7057–7069, Mar. 2024.